Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
The effect of Saccharomyces boulardii CNCM I-745 in the prevention of gluten immunopathology
FY 2023-24
Summary
Celiac disease results in the flattening of the finger-like projections of the gut lining when individuals with certain risk genes consume gluten-containing cereals. Gluten is a group of proteins that our body has difficulty digesting, where healthy individuals have gut microbes that can digest gluten to fragments that are no longer harmful. However, we found that microbes of celiac disease patients are less efficient at performing this task and at degrading essential amino acids (the building blocks of proteins) such as tryptophan. The latter leads to lower production of molecules (“metabolites”) that are important to maintain a healthy gut lining. Work from our lab in mice discovered that the yeast probiotic, Sacchromyces boulardii (S. bou) CNCM I-745, increases gluten digestion and tryptophan degradation. However, whether S. bou requires the resident gut microbes to perform this function, and which ones, is unknown. I propose to isolate gut bacteria and grow them in plates with gluten or the high-tryptophan protein casein, in the presence or absence of S. bou. Under these conditions, I will study a) gluten digestion, and b) tryptophan degradation resulting in the production of beneficial metabolites known to be important for gut lining protection. Currently, the only treatment for celiac disease is a strict gluten-free diet for life, which is difficult to achieve, is expensive and sometimes fails, leading to complications such as nutritional deficiencies, bone fractures, and higher risk of certain cancers. Our long-term goal is to unravel the conditions required for optimal gluten detoxification and tryptophan degradation, to guide clinical testing of an approved yeast probiotic in patients with celiac disease that do not respond to the gluten-free diet.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506119
Name
Kan Kelly R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effect of Saccharomyces boulardii CNCM I-745 in the prevention of gluten immunopathology
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ahr; Celiac Disease; Dietary Tryptophan; Gluten; Gluten Sensitivity; Gut Microbiota; Mouse Modeling; Probiotic; Saccharomyces Boulardii Cncm I-745; Tryptophan Metabolism
Abstract
Celiac disease results in the flattening of the finger-like projections of the gut lining when individuals with certain risk genes consume gluten-containing cereals. Gluten is a group of proteins that our body has difficulty digesting, where healthy individuals have gut microbes that can digest gluten to fragments that are no longer harmful. However, we found that microbes of celiac disease patients are less efficient at performing this task and at degrading essential amino acids (the building blocks of proteins) such as tryptophan. The latter leads to lower production of molecules (“metabolites”) that are important to maintain a healthy gut lining. Work from our lab in mice discovered that the yeast probiotic, Sacchromyces boulardii (S. bou) CNCM I-745, increases gluten digestion and tryptophan degradation. However, whether S. bou requires the resident gut microbes to perform this function, and which ones, is unknown. I propose to isolate gut bacteria and grow them in plates with gluten or the high-tryptophan protein casein, in the presence or absence of S. bou. Under these conditions, I will study a) gluten digestion, and b) tryptophan degradation resulting in the production of beneficial metabolites known to be important for gut lining protection. Currently, the only treatment for celiac disease is a strict gluten-free diet for life, which is difficult to achieve, is expensive and sometimes fails, leading to complications such as nutritional deficiencies, bone fractures, and higher risk of certain cancers. Our long-term goal is to unravel the conditions required for optimal gluten detoxification and tryptophan degradation, to guide clinical testing of an approved yeast probiotic in patients with celiac disease that do not respond to the gluten-free diet.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kan, Kelly R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~